Addition of bevacizumab to chemotherapy for treatment of solid tumors: similar results but different conclusions

J Clin Oncol. 2011 Jan 20;29(3):254-6. doi: 10.1200/JCO.2010.32.0275. Epub 2010 Dec 13.
No abstract available

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use*
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Combined Chemotherapy Protocols
  • Bevacizumab
  • Clinical Trials, Phase III as Topic / statistics & numerical data
  • Data Interpretation, Statistical
  • Female
  • Humans
  • Male
  • Neoplasms / drug therapy*
  • Randomized Controlled Trials as Topic / statistics & numerical data
  • Survival Analysis
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors*

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Vascular Endothelial Growth Factor A
  • Bevacizumab